| __timestamp | Taro Pharmaceutical Industries Ltd. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 179279000 | 60987000 |
| Thursday, January 1, 2015 | 186359000 | 125542000 |
| Friday, January 1, 2016 | 171785000 | 210460000 |
| Sunday, January 1, 2017 | 208136000 | 275119000 |
| Monday, January 1, 2018 | 198405000 | 409539000 |
| Tuesday, January 1, 2019 | 224169000 | 547758000 |
| Wednesday, January 1, 2020 | 245044000 | 736300000 |
| Friday, January 1, 2021 | 252314000 | 904200000 |
| Saturday, January 1, 2022 | 268225000 | 1080300000 |
| Sunday, January 1, 2023 | 304629000 | 1262200000 |
| Monday, January 1, 2024 | 324203000 | 1530500000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial for investors and stakeholders. Over the past decade, Vertex Pharmaceuticals Incorporated and Taro Pharmaceutical Industries Ltd. have shown distinct trends in their cost of revenue. From 2014 to 2023, Taro's costs increased by approximately 81%, reflecting a steady growth trajectory. In contrast, Vertex's costs surged by over 1,900%, highlighting its aggressive expansion and investment in research and development.
These insights reveal the contrasting strategies of these pharmaceutical giants, with Vertex focusing on rapid expansion and Taro maintaining steady growth.
Cost of Revenue Comparison: Novo Nordisk A/S vs Vertex Pharmaceuticals Incorporated
Cost of Revenue Comparison: AstraZeneca PLC vs Taro Pharmaceutical Industries Ltd.
Cost Insights: Breaking Down Pfizer Inc. and Taro Pharmaceutical Industries Ltd.'s Expenses
Comparing Cost of Revenue Efficiency: Vertex Pharmaceuticals Incorporated vs Regeneron Pharmaceuticals, Inc.
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Intra-Cellular Therapies, Inc.
Cost of Revenue: Key Insights for Vertex Pharmaceuticals Incorporated and ADMA Biologics, Inc.
Cost of Revenue Trends: Vertex Pharmaceuticals Incorporated vs Dyne Therapeutics, Inc.
Comparing Innovation Spending: Vertex Pharmaceuticals Incorporated and Taro Pharmaceutical Industries Ltd.
Xenon Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: MorphoSys AG vs Taro Pharmaceutical Industries Ltd.
Cost Insights: Breaking Down Taro Pharmaceutical Industries Ltd. and Dyne Therapeutics, Inc.'s Expenses
Cost of Revenue Trends: Taro Pharmaceutical Industries Ltd. vs Celldex Therapeutics, Inc.